Claims
- 1. An isolated nucleic acid fragment encoding all or a substantial portion of an anthranilate phosphoribosyltransferase comprising a member selected from the group consisting of:
(a) an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:6; (b) an isolated nucleic acid fragment that is substantially similar to an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:6; and (c) an isolated nucleic acid fragment that is complementary to (a) or (b).
- 2. The isolated nucleic acid fragment of claim 1 wherein the nucleotide sequence of the fragment comprises all or a portion of the sequence set forth in a member selected from the group consisting of SEQ ID NO:1, SEQ ID NO:3 and SEQ ID NO:5.
- 3. A chimeric gene comprising the nucleic acid fragment of claim 1 operably linked to suitable regulatory sequences.
- 4. A transformed host cell comprising the chimeric gene of claim 3.
- 5. A anthranilate phosphoribosyltransferase polypeptide comprising all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:6.
- 6. An isolated nucleic acid fragment encoding all or a substantial portion of an indole-3-glycerol phosphate synthase comprising a member selected from the group consisting of:
(a) an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:14 and SEQ ID NO:16; (b) an isolated nucleic acid fragment that is substantially similar to an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:14 and SEQ ID NO:16; and (c) an isolated nucleic acid fragment that is complementary to (a) or (b).
- 7. The isolated nucleic acid fragment of claim 6 wherein the nucleotide sequence of the fragment comprises all or a portion of the sequence set forth in a member selected from the group consisting of SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13 and SEQ ID NO:15.
- 8. A chimeric gene comprising the nucleic acid fragment of claim 6 operably linked to suitable regulatory sequences.
- 9. A transformed host cell comprising the chimeric gene of claim 8.
- 10. A indole-3-glycerol phosphate synthase polypeptide comprising all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:14 and SEQ ID NO:16.
- 11. An isolated nucleic acid fragment encoding all or a substantial portion of a phosphoribosylanthranilate isomerase comprising a member selected from the group consisting of:
(a) an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22 and SEQ ID NO:24; (b) an isolated nucleic acid fragment that is substantially similar to an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22 and SEQ ID NO:24; and (c) an isolated nucleic acid fragment that is complementary to (a) or (b).
- 12. The isolated nucleic acid fragment of claim 11 wherein the nucleotide sequence of the fragment comprises all or a portion of the sequence set forth in a member selected from the group consisting of SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21 and SEQ ID NO:23.
- 13. A chimeric gene comprising the nucleic acid fragment of claim 11 operably linked to suitable regulatory sequences.
- 14. A transformed host cell comprising the chimeric gene of claim 13.
- 15. A phosphoribosylanthranilate isomerase polypeptide comprising all or a substantial portion of the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22 and SEQ ID NO:24.
- 16. A method of altering the level of expression of a tryptophan biosynthetic enzyme in a host cell comprising:
(a) transforming a host cell with the chimeric gene of any of claims 3, 8 and 13; and (b) growing the transformed host cell produced in step (a) under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of altered levels of a tryptophan biosynthetic enzyme in the transformed host cell.
- 17. A method of obtaining a nucleic acid fragment encoding all or a substantial portion of the amino acid sequence encoding a tryptophan biosynthetic enzyme comprising:
(a) probing a cDNA or genomic library with the nucleic acid fragment of any of claims 1, 6 and 11; (b) identifying a DNA clone that hybridizes with the nucleic acid fragment of any of claims 1, 6 and 11; (c) isolating the DNA clone identified in step (b); and (d) sequencing the cDNA or genomic fragment that comprises the clone isolated in step (c) wherein the sequenced nucleic acid fragment encodes all or a substantial portion of the amino acid sequence encoding a tryptophan biosynthetic enzyme.
- 18. A method of obtaining a nucleic acid fragment encoding a substantial portion of an amino acid sequence encoding a tryptophan biosynthetic enzyme comprising:
(a) synthesizing an oligonucleotide primer corresponding to a portion of the sequence set forth in any of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21 and 23; and (b) amplifying a cDNA insert present in a cloning vector using the oligonucleotide primer of step (a) and a primer representing sequences of the cloning vector wherein the amplified nucleic acid fragment encodes a substantial portion of an amino acid sequence encoding a tryptophan biosynthetic enzyme.
- 19. The product of the method of claim 17.
- 20. The product of the method of claim 18.
- 21. A method for evaluating at least one compound for its ability to inhibit the activity of a tryptophan biosynthetic enzyme, the method comprising the steps of:
(a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment encoding a tryptophan biosynthetic enzyme, operably linked to suitable regulatory sequences; (b) growing the transformed host cell under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of the tryptophan biosynthetic enzyme encoded by the operably linked nucleic acid fragment in the transformed host cell; (c) optionally purifying the tryptophan biosynthetic enzyme expressed by the transformed host cell; (d) treating the tryptophan biosynthetic enzyme with a compound to be tested; and (e) comparing the activity of the tryptophan biosynthetic enzyme that has been treated with a test compound to the activity of an untreated tryptophan biosynthetic enzyme, thereby selecting compounds with potential for inhibitory activity.
- 22. The method of claim 21 wherein the tryptophan biosynthetic enzyme is a member selected from the group consisting of anthranilate phosphoribosyltransferase, indole-3-glycerol phosphate synthase and phosphoribosylanthranilate isomerase.
- 23. The method of claim 22 wherein the tryptophan biosynthetic enzyme is indole-3-glycerol phosphate synthase.
Parent Case Info
[0001] This application claims the benefit of U.S. Provisional Application No. 60/079386, filed Mar. 26, 1998.
Divisions (1)
|
Number |
Date |
Country |
Parent |
09647224 |
Jul 2001 |
US |
Child |
10295220 |
Nov 2002 |
US |